1-2 of 2
Jami L. Brown
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

Matthew J. Frigault, Kathleen M.E. Gallagher, Marc Wehrli, Betsy Valles, Keagan Casey, Kevin Lindell, Michael Trailor, Hana Cho, Jami L. Brown, Nora K. Horick, Justin Chou, Rhine R. Shen, Simone Filosto, Adrian Bot, Marcela V. Maus
Journal: Blood
Blood (2021) 138 (Supplement 1): 2814.
https://doi.org/10.1182/blood-2021-146927
Published: 2021
Journal Articles

A Phase I Study of the IDH2 Inhibitor Enasidenib As Maintenance Therapy for IDH2 -Mutant Myeloid Neoplasms Following Hematopoietic Cell Transplantation

Amir T. Fathi, Shuli Li, PhD, Robert J. Soiffer, MD, Mark Levis, MD PhD, Alice S. Mims, MD, Steven M Devine, MD, Zachariah Defilipp, MD, Areej El-Jawahri, MD, Steven L. McAfee, MD, Thomas R. Spitzer, MD, Matthew J Frigault, MD MSc, Bimalangshu R. Dey, MD, Philip C. Amrein, MD, Gabriela S. Hobbs, MD, Andrew M. Brunner, MD, Hanno R. Hock, MD PhD, Rupa Narayan, Laura W. Knight, Devon Kelley, AJ S. Bottoms, Jami L. Brown, MS, Candice J. Del Rio, RN, MS, Julie E. Vanderklish, ANP, Colleen Danielson, NP, Meredith L. Saylor, NP, Chrisa L. Hunnewell, Lindsey H. Perry, Jonathan L. Wahl, Elayne Breton, Vincent T. Ho, MD, Yi-Bin Chen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-140176
Published: 2020